Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study [1]

Katsuyuki Hotta, Akira Inoue, Katsuyuki Kiura, Hiroshi Ueoka, Mitsune Tanimoto, Toshihiro Nukiwa

Research output: Contribution to journalLetterpeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study [1]'. Together they form a unique fingerprint.